The news feeds on this site are independently provided by Adfero Limited © and do not represent the views or opinions of the World Gold Council.

Thursday, 21st September 2006 (5720 views)

The science of gold nanoparticles is allowing businesses in the UK to thrive, the Financial Times reports.

One such company is Oxonica, a nanotechnology firm based near Oxford and that was spun out from Oxford University in 2001.

Originally focusing on developing phosphor dots for display screens, Oxonica now uses gold nanoparticles in the healthcare business field.

"We are focused on driving up our revenues so that we can demonstrate as soon as possible that we can make money from nanotech," said chief executive Kevin Matthews.

"We have a huge opportunity to develop diagnostics that will be much cheaper at the point of use, enabling any GP to obtain an instant result for a patient, rather than sending the test away to a lab."

Among Oxonica's products are Envirox, a fuel borne nanocatalyst that can reduce the fuel consumption of diesel engines by between five and ten per cent, as well as lower particulate emissions by up to 15 per cent.

Its Optisol UV absorber gives better protection against UVA in sun-care products.

 

« Back to Gold News stories